Skip to main content

Table 5 Univariate and multivariate Cox regression analyses of SLC2A3 expression and the clinicopathological factors in the validation set (GSE39582)

From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data

  Overall survival Disease-free survival
HR(95% CI of HR) P valuea HR(95% CI of HR) P valuea
SLC2A3 low 1.00 (Reference)   1.00 (Reference)  
UVA SLC2A3 high 1.57 (1.16–2.12) 0.004 1.46 (1.06–2.01) 0.021
MVA SLC2A3 high 1.50 (1.11–2.03) 0.009 1.38 (1.00–1.91) 0.048
Age < = 65 1.00 (Reference)    
Age > 65 1.39 (1.01–1.91) 0.043   
AJCC stage I, II 1.00 (Reference)   1.00 (Reference)  
AJCC stage III, IV 1.82 (1.34–2.46) < 0.001 2.84 (2.03–3.98) < 0.001
  1. Abbreviations: HR hazard ratio, CI confidence interval, UVA univariate; MVA,multivariate
  2. aCalculated using the Wald test